Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 23, Issue 4, 1999, Pages 270-279

  Vincent, Françoise ^a   Bessard, Janine ^a   Vacheron, Jérôme ^a   Mallaret, Michel ^a   Bessard, Germain ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT; NORBUPRENORPHINE; THEBAINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; MASS SPECTROMETRY; QUANTITATIVE ASSAY; URINALYSIS;

EID: 0032813995     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/23.4.270     Document Type: Article

References (38)

1. J.W. Lewis. Buprenorphine. Drug Alcohol Depend. 14: 363-372 (1985).
2. A. Tracqui, C. Tournoud, F. Flesch, J. Kopferschmitt, P. Kintz, M. Deveaux, M.H. Ghysel, P. Marquet, G. Pépin, G. Petit, A. Jaeger, and B. Ludes. Intoxications aigües par traitement substitutif à base de buprénorphine haut dosage. Presse Méd. 27: 557-561 (1998).
3. ®) et benzodiazépines: 4 cas. J. Méd. Lég. Droit Méd. 40: 213-223 (1997).
4. T. Mieczkowski. The use of hair analysis for the detection of drugs: an overview. J. Clin. Forensic Med. 3: 59-71 (1996).
5. M.R. Moeller. Drug detection in hair by chromatographic procedures. J. Chromatogr. 580: 125-134 (1992).
6. L. Debrabandere, M. Van Boven, L. Laruelle, and P. Daenens. Routine detection of buprenorphine in horse urine: possibilities and limitations of the combined use of radioimmunoassay, liquid chromatography and gas chromatography-mass spectrometry. Anal. Chim. Acta. 275: 295-303 (1993).
7. C.W. Hand, K.E. Ryan, S.K. Dutt, R.A. Moore, J. O'Connor, D. Talbot, and H.J. McQuay. Radioimmunoassay of buprenorphine in urine: studies in patients in a drug clinic. J. Anal. Toxicol. 13: 100-104 (1989).
8. P. Kintz, V. Cirimele, Y. Edel, C. Jamey, and P. Mangin. Hair analysis for buprenorphine and its dealkylated metabolite by radioimmunoassay and confirmation by LC-ECD. J. Forensic Sci. 39: 1497-1503 (1994).
9. L. Debrabandere, M. Van Boven, and P. Daenens. Development of a fluoroimmunoassay for the detection of buprenorphine in urine. J. Forensic Sci. 40: 250-253 (1995).
10. D. Martinez, M.C. Jurado, and M. Repetto. Analysis of buprenorphine in plasma and urine by gas chromatography. J. Chromatogr. 528: 459-463 (1990).
11. E.J. Cone, C.W. Gorodetzky, D. Yousefnejad, W.F. Buchwald, and R.E. Johnson. The metabolism and excretion of buprenorphine in humans. Drug Metab. and Dispos. 12: 577-581 (1984).
12. 63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces. J. Chromatogr. 337: 291-300 (1985).
13. Y. Blom, U. Bondesson, and E. Änggard. Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. J. Chromatogr. 338: 89-98 (1985).
14. S.T. Ho, J.J. Wang, W. Ho, and O.Y.P. Hu. Determination of buprenorphine by high-performance liquid chromatography with fluorescence detection: application to human and rabbit pharmacokinetic studies. J. Chromatogr. 570: 339-350 (1991).
15. L. Debrabandere, M. Van Boven, and P. Daenens. Analysis of buprenorphine in urine specimens. J. Forensic Sci. 37: 82-89 (1991).
16. L. Debrabandere, M. Van Boven, and P. Daenens. High-performance liquid chromatography with electrochemical detection of buprenorphine and its major metabolite in urine. J. Chromatogr. 564: 557-566 (1991).
17. E. Schleyer, R. Lohmann, C. Rolf, A. Gralow, C.C. Kaufmann, M. Unterhalt, and W. Hiddemann. Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection. J. Chromatogr. 614: 275-283 (1993).
18. P. Kintz. Determination of buprenorphine and its dealkylated metabolite in human hair. J. Anal. Toxicol. 17: 443-444 (1993).
19. D.E. Moody, J.D. Laycock, A.C. Spanbauer, D.J. Crouch, R.L. Foltz, J.L. Josephs, L. Amass, and W.K. Bickel. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 21: 406-414 (1997).
20. M. Ohtani, F. Shibuya, H. Kotaki, K. Uchuno, Y. Saitoh, and F. Makagawa. Quantitative determination of buprenorphine and its active metabolite, norbuprenorphine, in human plasma by gas chromatography-chemical ionization mass spectrometry. J. Chromatogr. 487: 469-475 (1989).
21. A. Tracqui, P. Kintz, and P. Mangin. High-performance liquid chromatographic mass spectrometry determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J. Forensic Sci. 42: 111-114 (1997).
22. H. Hoja, P. Marquet, B. Verneuil, H. Lotfi, J.L. Dupuy, M.F. Dreyfuss, and G. Lachâtre. Dosage de buprénorphine et de norbuprénorphine dans l'urine et le sérum par chromatographie liquide couplée à la spectrométrie de masse avec ionisation de type électrospray. Analusis 24: 104-107 (1996).
23. H. Hoja, P. Marquet, B. Verneuil, H. Lotfi, J.L. Dupuy, and G. Lachâtre. Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 21: 160-165 (1997).
24. J.J. Kuhlman, J. Magluilo, E. Cone, and B. Levine. Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry. J. Anal. Toxicol. 20: 229-235 (1996).
25. M. Ohtani, H. Kotaki, Y. Sawada, and T. Iga. Comparative analysis of buprenorphine and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J. Pharmacol. Exp. Ther. 272: 505-510 (1995).
26. M. Ohtani, H. Kotaki, K. Nishitateno, Y. Sawada, and T. Iga. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. J. Pharmacol. Exp. Ther. 281: 428-433 (1997).
27. R.W. Romberg and L. Lee. Comparison of the hydrolysis rates of morphine-3-glucuronide and morphine-6-glucuronide with acid and β-glucuronidase. J. Anal. Toxicol. 19: 157-162 (1995).
28. W.A. Baumgartner, V.A. Hill, and W.H. Blahd. Hair analysis for drugs of abuse. J. Forensic Sci. 34: 1433-1453 (1989).
29. P. Kintz and P. Mangin. What constitutes a positive result in hair analysis: proposal for the establishment of cut-off values. Forensic Sci. Int. 70: 3-11 (1995).
30. Society of Hair Testing. Forensic Sci. Int. 84: 3-6 (1997).
31. M. Welch, L. Sniegoski, and C. Allgood. Interlaboratory comparison studies on the analysis of hair for drugs of abuse. Forensic Sci. Int. 63: 295-303 (1993).
32. L. Sniegoski and M. Welch. Interlaboratory studies on the analysis of hair for drugs of abuse: results from the fourth exercise. J. Anal. Toxicol. 20: 242-247 (1996).
33. P. Kintz. Interlaboratory comparison of quantitative determinations of drugs in hair samples. Forensic Sci. Int. 70: 105-109 (1995).
34. J.G. Lloyd-Jones, P. Robinson, R. Henson, S.R. Biggs, and T. Taylor. Plasma concentration and disposition of buprenorphine after intravenous and intramuscular doses to baboons. Eur. J. Drug Metab. Pharmacokinet. 5: 233-239 (1980).
35. G. Amalfitano, J. Bessard, F. Vincent, H. Eysseric, and G. Bessard. Gas chromatographic quantification of dextropropoxyphene and norpropoxyphene in urine after solid-phase extraction. J. Anal. Toxicol. 20: 547-554 (1996).
36. G. Van Look, G. Simchen, and J. Heberle. Silylating Agents, 2nd ed. Fluka Chemie A.G. Buchs, Switzerland, 1995, pp 13-53.
37. Y.C. Yoo, H.S. Chung, I.S. Kim, W.T. Jin, and M.K. Kim. Determination of nalbuphine in drug abusers' urine. J. Anal. Toxicol. 19: 120-123 (1995).
38. A.S. Valdez, D.G. Wilkins, M.H. Slawson, C. Sison, W. Ling, and D.E. Rollins. Buprenorphine and norbuprenorphine in human hair of substance abuse treatment subjects. Poster presented in College on Problems of Drug Dependence, 60th annual scientific meeting, Scottsdale, AZ, 1998.